Scirica, B.M., Cannon, C.P., Cooper, R., et al. (2006) Drug-Induced Thrombocytopenia and Thrombosis: Evidence from Patients Receiving an Oral Glycoprotein IIb/IIIa Inhibitor in the Orbofiban in Patients with Unstable Coronary Syndromes-(OPUS-TIMI 16) Trial. Journal of Thrombosis and Thrombolysis, 22, 95-102.

has been cited by the following article:

• TITLE: Severe Isolated Thrombocytopenia Associated with the Use of Clopidogrel

  AUTHORS: Yingying Zhang, Hongyan Zhou, Wei Han

  KEYWORDS: Clopidogrel, Antiplatelet, Thrombocytope

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.3 No.4, April 16, 2014

  ABSTRACT: Clopidogrel is used as a frontline antiplatelet drug in patients with coronary artery disease, peripheral vascular disease and cerebrovascular disease. Though it is frequently reported that clopidogrel is associated with thrombotic thrombocytopenic purpura (TTP), severe isolated thrombocytopenia induced by this drug is rare. Here we report a case with isolated thrombocytopenia due to clopidogrel therapy. As this agent is widely used in clinical practice, the occurrence of this rare but dangerous adverse effect should be considered.